Archambault, A.-S.; Brassard, J.; Bernatchez, É.; Martin, C.; Di Marzo, V.; Laviolette, M.; Boulet, L.-P.; Blanchet, M.-R.; Flamand, N.
Human and Mouse Eosinophils Differ in Their Ability to Biosynthesize Eicosanoids, Docosanoids, the Endocannabinoid 2-Arachidonoyl-glycerol and Its Congeners. Cells 2022, 11, 141.
https://doi.org/10.3390/cells11010141
AMA Style
Archambault A-S, Brassard J, Bernatchez É, Martin C, Di Marzo V, Laviolette M, Boulet L-P, Blanchet M-R, Flamand N.
Human and Mouse Eosinophils Differ in Their Ability to Biosynthesize Eicosanoids, Docosanoids, the Endocannabinoid 2-Arachidonoyl-glycerol and Its Congeners. Cells. 2022; 11(1):141.
https://doi.org/10.3390/cells11010141
Chicago/Turabian Style
Archambault, Anne-Sophie, Julyanne Brassard, Émilie Bernatchez, Cyril Martin, Vincenzo Di Marzo, Michel Laviolette, Louis-Philippe Boulet, Marie-Renée Blanchet, and Nicolas Flamand.
2022. "Human and Mouse Eosinophils Differ in Their Ability to Biosynthesize Eicosanoids, Docosanoids, the Endocannabinoid 2-Arachidonoyl-glycerol and Its Congeners" Cells 11, no. 1: 141.
https://doi.org/10.3390/cells11010141
APA Style
Archambault, A.-S., Brassard, J., Bernatchez, É., Martin, C., Di Marzo, V., Laviolette, M., Boulet, L.-P., Blanchet, M.-R., & Flamand, N.
(2022). Human and Mouse Eosinophils Differ in Their Ability to Biosynthesize Eicosanoids, Docosanoids, the Endocannabinoid 2-Arachidonoyl-glycerol and Its Congeners. Cells, 11(1), 141.
https://doi.org/10.3390/cells11010141